Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORAZEPAM vs OXAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORAZEPAM vs OXAZEPAM: Safety Overview

Metric LORAZEPAM OXAZEPAM
Total FAERS Reports 33,404 12,440
Deaths Reported 6,187 2,965
Death Rate 18.5% 23.8%
Hospitalizations 15,431 6,242
Average Patient Age 49.8 yrs 57.3 yrs
% Female Patients 60.8% 58.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Hikma Pharmaceuticals USA Inc. Aphena Pharma Solutions - Tennessee, LLC
Route INTRAMUSCULAR ORAL
Marketing Status Prescription Discontinued